Nick DeLong
Corporate Officer/Principal at IBIO, INC.
Profile
Nick DeLong is the founder of Evolved Capital, Inc. He currently holds the position of Vice President-Corporate Development at iBio, Inc. Previously, he worked as Head-Business Development at Tris Pharma, Inc. Dr. DeLong holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Rutgers University-Newark.
Nick DeLong active positions
| Companies | Position | Start |
|---|---|---|
| IBIO, INC. | Corporate Officer/Principal | - |
Former positions of Nick DeLong
| Companies | Position | End |
|---|---|---|
| Evolved Capital, Inc. | Founder | - |
Tris Pharma, Inc.
 Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Tris Pharma, Inc. engages in the provision of specialty pharmaceutical cervices. It focuses on the development of pharmaceutical science and technology-based products. The company was founded by Ketan Mehta in 2000 and is headquartered in Monmouth Junction, NJ. | Corporate Officer/Principal | - |
Training of Nick DeLong
| University of Pennsylvania | Doctorate Degree |
| Rutgers University- Newark | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| IBIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Tris Pharma, Inc. engages in the provision of specialty pharmaceutical cervices. It focuses on the development of pharmaceutical science and technology-based products. The company was founded by Ketan Mehta in 2000 and is headquartered in Monmouth Junction, NJ. | Health Technology |
| Evolved Capital, Inc. | Technology Services |
- Stock Market
- Insiders
- Nick DeLong
